
Viracta Therapeutics Announces Wind Down of Operations

I'm PortAI, I can summarize articles.
SAN DIEGO, Feb. 05, 2025 ( GLOBE NEWSWIRE ) -- Viracta Therapeutics, Inc. ( Nasdaq: VIRX ) , a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, announced today that the Company has terminated its ...

